7 research outputs found
Inefficiency and Environmental Risks associated with Nutrient Use in Agriculture within China and the UK
The stocks and flows of nitrogen (N) and phosphorus (P) were quantified for five case studies, representing contrasting agricultural systems in China and the UK. The input of nutrients exceeded the output of nutrients in agricultural products for all five systems, although to varying degrees between individual case studies.Excessive input of nutrients for each system increases the risk of negative environmental impacts on soil, air and water quality. Soils accumulate nutrient stocks due to excessive nutrient inputs, representing an under-exploited nutrient reserve that could contribute to future agriculture production. Livestock and crop production are increasingly disconnected in China. Manure application was limited to high-value fruit and vegetable crops in the systems analysed, but often without adequate accounting for the nutrient content of the applied manure.Pathways to improve the efficiency of nutrient use are identified
Competitive adsorption of NOx and ozone on the catalyst surface of ozone converters: In-Situ DRIFTS Measurements
International audienc
Competitive adsorption of NOx and ozone on the catalyst surface of ozone converters: In-Situ DRIFTS Measurements
International audienc
Competitive adsorption of NOx and ozone on the catalyst surface of ozone converters: In-Situ DRIFTS Measurements
International audienc
Recommended from our members
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study.
BACKGROUND
Chronic liver disease (CLD) and cirrhosis are associated with immune dysregulation leading to concerns that these patients may be at risk of adverse outcomes following SARS-CoV-2 infection. However, the impact of COVID-19 among patients with pre-existing liver disease remains ill-defined.
METHODS
Data for CLD patients with SARS-CoV-2 were collected by two international registries. Comparisons were made with non-CLD patients with SARS-CoV-2 from a UK hospital network.
RESULTS
Between 25th March and 8th July 2020, 745 CLD patients were reported from 29 countries including 386 with cirrhosis and 359 without. Mortality was 32% in patients with cirrhosis compared with 8% in those without (p<0.001). Mortality in cirrhosis patients increased according to Child-Turcotte-Pugh class (CTP-A (19%), CTP-B (35%), CTP-C (51%)) and the main cause of death was respiratory failure (71%). After adjusting for baseline characteristics, factors associated with death in the total CLD cohort were age (OR 1.02; 1.01-1.04), CTP-A (OR 1.90; 1.03-3.52), CTP-B (OR 4.14; 2.4-7.65), CTP-C cirrhosis (OR 9.32; 4.80-18.08) and alcohol related liver disease (ALD) (OR 1.79; 1.03-3.13). When comparing CLD versus non-CLD (n=620) in propensity-score-matched analysis there were significant increases in mortality with CTP-B +20.0% (8.8%-31.3%) and CTP-C cirrhosis +38.1% (27.1%-49.2%). Acute hepatic decompensation occurred in 46% of patients with cirrhosis, of which 21% had no respiratory symptoms. 50% of those with hepatic decompensation had acute-on-chronic liver failure.
CONCLUSIONS
This is the largest reported cohort of CLD and cirrhosis patients with SARS-CoV-2 infection to date. We demonstrate that baseline liver disease stage and ALD are independent risk factor for death from COVID-19. These data have important implications for the risk stratification of patients with CLD across the globe during the COVID-19 pandemic